‘A supercharged incubator compared with Australia’: GP’s three years with US tech entrepreneurs
Dr Michael Bonning on working in med-tech on the cusp of the AI boom.
The US technology and entrepreneur scene wants Australian GPs.
That was at least the experience of Dr Michael Bonning, former AMA NSW president, as he spent three years in New York working with a company that would make, according to Time magazine, one of last year’s top 200 best inventions.
From 2017 to 2019, Dr Bonning was Medical Director of DermaSensor, helping to develop the “world’s first point-and-click skin cancer detection tool”, combining elastic scattering spectroscopy and AI to interpret the data.
With the company — where he remains medical advisor after his return to Australia — he brought the DermaSensor system from early clinical trials to being ready for commercial sales.
